Stockreport

Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com